Erythrocyte Complement Receptor 1 and Alzheimer Disease
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01565434 |
Recruitment Status :
Completed
First Posted : March 28, 2012
Last Update Posted : June 9, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Alzheimer Disease | Other: CR1 impact | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 200 participants |
Primary Purpose: | Screening |
Study Start Date : | February 2012 |
Actual Study Completion Date : | April 2015 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- caucasians people with a Alzheimer dementia defined on DSMIV criteria for patients and without Alzheimer disease for control subjects
Exclusion Criteria:
- diseases modifying CR1 physiology

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01565434
France | |
CHU de REIMS | |
Reims, France, 51092 |
Responsible Party: | CHU de Reims |
ClinicalTrials.gov Identifier: | NCT01565434 |
Other Study ID Numbers: |
PA11014 |
First Posted: | March 28, 2012 Key Record Dates |
Last Update Posted: | June 9, 2016 |
Last Verified: | March 2012 |
Alzheimer Disease Dementia Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Tauopathies Neurodegenerative Diseases Neurocognitive Disorders Mental Disorders |